Lung Cancer | Oncology Today with Dr Neil Love: NSCLC with EGFR Exon 20 Insertion Mutations - a podcast by Dr Neil Love

Featuring an interview with Dr Gregory Riely, including the following topics:

• EGFR exon 20 insertions in non-small cell lung cancer (NSCLC) (0:00)
• Antitumor activity, mechanism of action and tolerability of mobocertinib for patients with NSCLC and EGFR exon 20 mutations (4:59)
• Antitumor activity and tolerability of the EGFR-MET bispecific antibody amivantamab (11:05)
• Considerations for using real-world data to create synthetic control arms for clinical trials (17:48)
• Novel investigational agents for and future management of NSCLC with EGFR exon 20 insertions (23:48)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love